Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04477863 · ClinicalTrials.gov registry record

Follow-up With Preimplantation Genetic Testing Patients

A clinical trial of Infertility and Genetic Disease, sponsored by Genomic Prediction.

Recruiting
Registry status
10,000
Enrollment target
1
Study location

NCT04477863 is a study of Infertility and Genetic Disease that is actively recruiting participants, run by Genomic Prediction. The registered enrollment target is 10,000 participants, above the 7,454-participant average among 74 other Infertility trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04477863, a study of Infertility and Genetic Disease, is actively recruiting participants, sponsored by Genomic Prediction.

RECRUITING
Registry status
10,000 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.

Interventions

  • OTHER Follow-up Interview

Study Locations (1)

New Jersey

  • Genomic Prediction Clinical Laboratory - North Brunswick

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2020-07-11
Est. Completion 2050-12-31

Sponsor

Genomic Prediction

6 total trials

What the Registry Record Tells You About NCT04477863

The ClinicalTrials.gov registry entry for NCT04477863 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 7,454-participant average among 74 other Infertility trials with a reported enrollment target (34% higher). The listed sponsor is Genomic Prediction, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Follow-up Interview is the first listed.

NCT04477863 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT04477863 about?

NCT04477863 is a clinical study titled "Follow-up With Preimplantation Genetic Testing Patients". The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for ...

What is the current status of trial NCT04477863?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2020-07-11. Estimated completion is 2050-12-31.

What conditions does trial NCT04477863 study?

This clinical trial studies the following conditions: Infertility, Genetic Disease, IVF.

What interventions are being tested in trial NCT04477863?

The interventions under investigation include: Follow-up Interview (OTHER).

Who is sponsoring clinical trial NCT04477863?

This trial is sponsored by Genomic Prediction, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04477863 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.